SUBSCRIBE
SUBSCRIBE

Preclinical

Bookmark and Share
Drug Development
Stem Cells: Cincinnati Children’s Hospital Medical Center Scientists Successfully Reprogram Blood Cells
November 12, 2009
 · 
1 min read
Drug Development
Developmental Drug May Help Bone Fractures Heal After Radiation Exposure, University of Pittsburgh School of Medicine Study
November 3, 2009
 · 
1 min read
Drug Development
Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers, University of Cincinnati and Leiden University Medical Center Study
November 2, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Drug-radiation Combo Eradicates Lung Cancer In Mice, UT Southwestern Medical Center Study
October 30, 2009
 · 
1 min read
Drug Development
Nervous System Drug-by-design: Formulation May Slow Parkinson’s, Alzheimer’s, Huntington’s, Tel Aviv University Study
October 27, 2009
 · 
1 min read
Drug Development
Cocaine Exposure During Pregnancy Leads To Impulsivity In Male, Not Female, Monkeys, Wake Forest University School of Medicine Study
October 26, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Dogs Aid In Advancing Human Cancer Therapy, National Cancer Institute Scientists Say
October 14, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Paralyzed Rats Walk Again, University of California, Los Angeles (UCLA) Scientist Use Drug-Electricity Combo to Make Paralyzed Rats Sprint
September 21, 2009
 · 
1 min read
Drug Development
Chocolate Treats Migraines, Mississippi State University Study
September 18, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Moths As Good As Mice For Many Drug Tests, National University Of Ireland Study
September 8, 2009
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Wugen Presents New Preclinical Data Demonstrating Enhanced Anti-Tumor Activity of WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress
June 10, 2022
 · 
3 min read
Drug Development
Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications
June 10, 2022
 · 
6 min read
Drug Development
Vincerx Pharma Presents Preclinical and Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Lymphoma at the European Hematology Association 2022 Congress
June 10, 2022
 · 
9 min read
Drug Development
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
June 10, 2022
 · 
6 min read
Drug Development
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 27th Annual Congress of the European Hematology Association
June 10, 2022
 · 
13 min read
Drug Development
Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress
June 10, 2022
 · 
6 min read
Drug Development
Kronos Bio Continues to Advance Investigational SYK Inhibitors Entospletinib and Lanraplenib with New Preclinical Data at EHA2022 Congress
June 10, 2022
 · 
6 min read
Drug Development
CyanVac Announces Data from Preclinical Studies of Intranasal PIV5-based COVID-19 Vaccine Candidate CVXGA1
June 9, 2022
 · 
7 min read
Drug Development
Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250 for the Treatment of Pancreatic Neuroendocrine Carcinoma
June 9, 2022
 · 
6 min read
Drug Development
Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH
June 9, 2022
 · 
4 min read
Drug Development
Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition
June 9, 2022
 · 
5 min read
Drug Development
Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120
June 9, 2022
 · 
2 min read
Drug Development
KalVista Pharmaceuticals Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program
June 8, 2022
 · 
4 min read
Drug Development
Oxurion Announces Preclinical Presentation on THR-149 at KININ2022
June 7, 2022
 · 
2 min read
Drug Development
Clearmind Medicine Announces Positive Pre-Clinical Results for Cocaine Addiction Treatment
June 7, 2022
 · 
4 min read
Drug Development
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based Therapeutics at the 2022 Neurofibromatosis (NF) Conference
June 7, 2022
 · 
1 min read
Drug Development
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
June 7, 2022
 · 
3 min read
Drug Development
Applied DNA and EvviVax Announce Peer-Reviewed Publication of Positive Preclinical Data for LinearDNA™ Platform as a Novel Cancer Vaccine Strategy in the Journal of Experimental & Clinical Cancer Research
June 6, 2022
 · 
6 min read
Drug Development
Eureka Therapeutics Announces Publication of Study Demonstrating Broad Anti-Tumor Activity of TCR Mimic-Redirected T Cells Targeting NDC80
June 6, 2022
 · 
2 min read
Drug Development
Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting
June 5, 2022
 · 
6 min read
Load More